Product References

Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B-cell Malignancy Patients
Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B-cell Malignancy Patients

Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B-cell Malignancy Patients

Pooled Human AB Serum Plasma Derived from Innovative Research was used in the following study:   Multiple Site Place-of-Care Manufactured...

Expression of Placenta-Specific 1 and its Potential for Eliciting Anti-Tumor Helper T-cell Responses in Head and Neck Squamous Cell Carcinoma
Expression of Placenta-Specific 1 and its Potential for Eliciting Anti-Tumor Helper T-cell Responses in Head and Neck Squamous Cell Carcinoma

Expression of Placenta-Specific 1 and its Potential for Eliciting Anti-Tumor Helper T-cell Responses in Head and Neck Squamous Cell Carcinoma

Pooled Human AB Serum Off The Clot from Innovative Research was used in the following study:   Expression of Placenta-Specific...

HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T-Cells are Selectively Activated with Amoxicillin-Peptide Adducts
HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T-Cells are Selectively Activated with Amoxicillin-Peptide Adducts

HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T-Cells are Selectively Activated with Amoxicillin-Peptide Adducts

Pooled Human AB Serum Plasma Derived from Innovative Research was used in the following study:   HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+...